CRT 2026

Live Case Broadcasting From Radbound University Medical Center | Nijmegen, the Netherlands

Live Case Operator(s)

• 

  Robert-Jan M. van Geuns, MD, PhD

  Cardiologist
  RadboudUMC
  Nijmegen, Gelderland, Netherlands

  Disclosure information not submitted.

Moderator(s)

• 

  Lorenzo Azzalini, MD, PhD, MSc

  Interventional Cardiologist
  University of Washington
  Seattle, Washington, United States

  Disclosure(s): Dr. Azzalini received consulting fees from Teleflex, Abiomed, GE Healthcare, Reflow Medical, Shockwave Medical, Abbott, Boston Scientific, XyloCor Therapeutics, HeartFlow, and Cardiovascular Systems, Inc.; and owns equity in Reflow Medical.: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Carlo Di Mario, MD

  Professor
  University of Florence
  Florence, Toscana, Italy

  Disclosure(s): Amgen: Grant/Research Support (Terminated, July 1, 2024); BSC: Grant/Research Support (Ongoing); Novo Nordisk: Grant/Research Support (Ongoing)
• 

  Allison B. Hall, MD, FRCPC

  Interventional Cardiologist, Clinical Assistant Professor of Medicine
  NL Health Services/Memorial University of Newfoundland
  St. John's, Newfoundland and Labrador, Canada

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Khaldoon Alaswad, MD, FACC, FSCAI

  Director, Catheterization Laboratory
  Henry Ford Hospital and Health System
  Detroit, Michigan, United States

  Disclosure(s): No financial relationships to disclose
• 

  Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC

  Consultant Cardiologist
  National Health Service

  Disclosure information not submitted.
• 

  Farouc A. Jaffer, MD, PhD

  Director Coronary Intervention and CTO PCI Program
  Massachusetts General Hospital / Harvard Medical School
  Boston, Massachusetts, United States

  Disclosure(s): Boston Scientific, Siemens, Magenta Medical, Philips, Biotronik, Mercator, Terumo, Abiomed, Shockwave, DurVena, i3, Medtronic, FastWave;: Consulting Fees (e.g., advisory boards) (Ongoing); Canon, Siemens, Shockwave, Teleflex, Mercator, Boston Scientific, HeartFlow, Neovasc; Orbus Neich: Grant/Research Support (Ongoing); Fastwave: Stock-privately held company (Ongoing); i3: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)
• 

  Jaikirshan Khatri, MD

  Director of Cardiac Catheterization Laboratory
  Weill Cornell Medical Center, United States

  Disclosure(s): Siemens, Neovasc/Shockwave, Teleflex, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Michael Megaly, MD

  Interventional cardiologist
  Ascension St John Medical Center
  Tulsa, Oklahoma, United States

  Disclosure(s): No financial relationships to disclose
• 

  Srini Potluri, MD

  Chief of Cardiology
  Baylor Scott and White The Heart Hospital Plano
  Frisco, Texas, United States

  Disclosure information not submitted.
• 

  John Daniel Puskas, MD PhD(hc)

  Professor of Cardiothoracic Surgery
  Emory University
  Atlanta, Georgia, United States

  Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Scanlan Inc: Royalties on sale of coronary surgery instruments designed by Puskas (Ongoing)
• 

  Stephane Rinfret, MD, SM

  Director of Complex Coronary Interventions
  Georgia Heart Institute
  Gainesville, Georgia, United States

  Disclosure information not submitted.
• 

  Gerald S. Werner, MD, PhD, FSCAI

  Senior Consultant CTO
  University Heart Center Frankfurt/Main
  Frankfurt am Main, Hessen, Germany

  Disclosure information not submitted.